Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05180981 · ClinicalTrials.gov registry record · NA
Imaging Brain Fluids During Breathing
A NA study of Healthy, sponsored by Boston University Charles River Campus.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 2
- Study locations
NCT05180981: Recruiting NA study of Healthy, sponsored by Boston University Charles River Campus.
NCT05180981 is a NA study of Healthy that is actively recruiting participants, run by Boston University Charles River Campus. The registered enrollment target is 80 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05180981, a NA study of Healthy, is actively recruiting participants, sponsored by Boston University Charles River Campus.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will perform magnetic resonance imaging (MRI) measurements of hemodynamics and cerebrospinal fluid flow across breathing tasks and during breath-locked neuromodulation.
Primary Outcome
fMRI measures of hemodynamic responses. Units: percent signal change
Conditions Studied
Interventions
- DEVICE Transcutaneous vagal nerve stimulation
- BEHAVIORAL Breathing task
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Boston
- Boston University - Charles River Campus - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-01-18 |
| Est. Completion | 2026-05-01 |
| Phase | NA |
What NCT05180981 shows while recruiting
NCT05180981 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Transcutaneous vagal nerve stimulation is the first listed.
NCT05180981 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05180981 about?
NCT05180981 is a clinical study titled "Imaging Brain Fluids During Breathing". This study will perform magnetic resonance imaging (MRI) measurements of hemodynamics and cerebrospinal fluid flow across breathing tasks and during breath-locked neuromodulation.
What is the current status of trial NCT05180981?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-01-18. Estimated completion is 2026-05-01.
What conditions does trial NCT05180981 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT05180981?
The interventions under investigation include: Transcutaneous vagal nerve stimulation (DEVICE), Breathing task (BEHAVIORAL).
Who is sponsoring clinical trial NCT05180981?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05180981 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05180981's enrollment target sits among peer trials
80 274th of 1090 higher than 802 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI